CY2017 Q1
Showing 1 to 10 of 10 rows
Loading, please wait
Company
|
Value
|
End Date
|
SEC Filing
|
|---|---|---|---|
| APPLIED GENETIC TECHNOLOGIES CORP | $169,000.00 | 2017-03-31 | View |
| AVALO THERAPEUTICS, INC. | $187,363.00 | 2017-03-31 | View |
| CAPRICOR THERAPEUTICS, INC. | $197,214.00 | 2017-03-31 | View |
| IMUNON, INC. | $141,622.00 | 2017-03-31 | View |
| KALVISTA PHARMACEUTICALS, INC. | $297,000.00 | 2017-04-30 | View |
| LISATA THERAPEUTICS, INC. | $5,700,000.00 | 2017-05-04 | View |
| Nexvet Biopharma plc | $1,195,000.00 | 2017-03-31 | View |
| PROTEO INC | $67,879.00 | 2017-03-31 | View |
| SOLIGENIX, INC. | $993,490.00 | 2017-03-31 | View |
| SPYRE THERAPEUTICS, INC. | $981,000.00 | 2017-03-31 | View |
SEC Filings Explorer
Formalu provides easy access to SEC filings and reporting data
Most Recent Filings
2000 most recent SEC filings for the current official filing date
Browse By Company
All SEC filings and reported GAAP facts from 2010 to now for every company
Formalu's Securities and Exchange Commission Page
SEC forms, contact information and locations